Investigate the heterogeneity of colorectal cancer patients at the single-cell level prior to and subsequent to immunotherapy
Artículo
Acceso abierto
Artículo
DOAJ
BackgroundImmune checkpoint blockade (ICB) has improved outcomes for a subset of colorectal cancer (CRC) patients, yet the cellular determinants that drive heterogeneous treatment responses remain insufficiently understo...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access